These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 7921964

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Protection against graft-versus-host disease by large doses of donor CD4+ T cells: a novel approach to bone marrow transplantation.
    Heath WR, Miller JF, Sprent J.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1222-4. PubMed ID: 8442095
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
    Sao H, Kitaori K, Kasai M, Shimokawa T, Kato C, Yamanishi H, Ueda R, Morishima Y.
    Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
    [Abstract] [Full Text] [Related]

  • 28. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
    Morishima Y, Yabe T, Matsuo K, Kashiwase K, Inoko H, Saji H, Yamamoto K, Maruya E, Akatsuka Y, Onizuka M, Sakamaki H, Sao H, Ogawa S, Kato S, Juji T, Sasazuki T, Kodera Y, Japan Marrow Donor Program.
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
    [Abstract] [Full Text] [Related]

  • 29. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR, Majewski D, Ozker K, Hanson G.
    J Immunol; 1998 Sep 01; 161(5):2610-9. PubMed ID: 9725263
    [Abstract] [Full Text] [Related]

  • 30. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM, Waller EK.
    Biol Blood Marrow Transplant; 2004 Aug 01; 10(8):540-51. PubMed ID: 15282532
    [Abstract] [Full Text] [Related]

  • 31. T-cell depletion in allogeneic bone marrow transplantation for acute leukaemias.
    Aversa F, Terenzi A, Carotti A, Velardi A, Latini P, Gambelunghe C, Grignani F, Martelli MF.
    Bone Marrow Transplant; 1989 Dec 01; 4 Suppl 4():69-72. PubMed ID: 2697440
    [No Abstract] [Full Text] [Related]

  • 32. A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.
    Davis JE, Harvey M, Gherardin NA, Koldej R, Huntington N, Neeson P, Trapani JA, Ritchie DS.
    Biol Blood Marrow Transplant; 2015 Feb 01; 21(2):242-9. PubMed ID: 25459639
    [Abstract] [Full Text] [Related]

  • 33. Prevention of graft-versus-host disease by ex vivo T cell depletion: reduction in graft failure with augmented total body irradiation.
    Burnett AK, Hann IM, Robertson AG, Alcorn M, Gibson B, McVicar I, Niven L, Mackinnon S, Hambley H, Morrison A.
    Leukemia; 1988 May 01; 2(5):300-3. PubMed ID: 3287016
    [Abstract] [Full Text] [Related]

  • 34. Bone marrow transplantation and graft-versus-host disease.
    Powles RL.
    Curr Opin Immunol; 1988 May 01; 2(6):870-5. PubMed ID: 2486567
    [No Abstract] [Full Text] [Related]

  • 35. T-cell depletion for bone marrow transplantation: effects on graft rejection, graft-versus-host disease, graft-versus-leukemia, and survival.
    Champlin RE.
    Cancer Treat Res; 1990 May 01; 50():99-111. PubMed ID: 1976361
    [Abstract] [Full Text] [Related]

  • 36. Relapse of host leukemic lymphoblasts following engraftment by an HLA-mismatched marrow transplant: mechanisms of escape from the "graft versus leukemia" effect.
    Sondel PM, Hank JA, Molenda J, Blank J, Borcherding W, Longo W, Trigg ME, Hong R, Bozdech MJ.
    Exp Hematol; 1985 Sep 01; 13(8):782-90. PubMed ID: 2931298
    [Abstract] [Full Text] [Related]

  • 37. T cell depletion in bone marrow transplantation for leukemia: current results and future directions.
    Butturini A, Gale RP.
    Bone Marrow Transplant; 1988 May 01; 3(3):185-92. PubMed ID: 3048485
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. T cell depletion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect.
    Henslee PJ, Thompson JS, Romond EH, Doukas MA, Metcalfe M, Marshall ME, MacDonald JS.
    Transplant Proc; 1987 Feb 01; 19(1 Pt 3):2701-6. PubMed ID: 3547948
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.